The native form and maturation process of hepatitis C virus core protein

被引:190
作者
Yasui, K
Wakita, T
Tsukiyama-Kohara, K
Funahashi, S
Ichikawa, M
Kajita, T
Moradpour, D
Wands, JR
Kohara, M
机构
[1] Tokyo Metropolitan Inst Med Sci, Dept Microbiol, Bunkyo Ku, Tokyo 113, Japan
[2] Tokyo Metropolitan Inst Neurosci, Tokyo, Japan
[3] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 602, Japan
[4] Chugai Res Inst Mol Med Inc, Ibaraki, Osaka, Japan
[5] Int Reagents Co, Ctr Res & Dev, Nishi Ku, Kobe, Hyogo, Japan
[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Hepatol Lab, Boston, MA USA
[7] Univ Hosp Freiburg, Dept Med, Freiburg, Germany
关键词
D O I
10.1128/JVI.72.7.6048-6055.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The maturation and subcellular localization of hepatitis C virus (HCV) core protein were investigated with both a vaccinia virus expression system and CHO cell lines stably transformed with HCV cDNA. Two HCV core proteins, with molecular sizes of 21 kDa (p21) and 23 kDa (p23), were identified. The C-terminal end of p23 is amino acid 191 of the HCV polyprotein, and p21 is produced as a result of processing between amino acids 174 and 191. The subcellular localization of the HCV core protein,vas examined by confocal laser scanning microscopy. Although HCV core protein resided predominantly in the cytoplasm, it was also found in the nucleus and had the same molecular size as p21 in both locations, as determined by subcellular fractionation. The HCV core proteins had different immunoreactivities to a panel of monoclonal antibodies. Antibody 5E3 stained core protein in both the cytoplasm and the nucleus, C7-50 stained core protein only in the cytoplasm, and 499S stained core protein only in the nucleus. These results clearly indicate that the p23 form of HCV core protein is processed to p21 in the cytoplasm and that the core protein in the nucleus has a higher-order structure different from that of p21 in the cytoplasm. HCV core protein in sera of patients with HCV infection was analyzed in order to determine the molecular size of genuinely processed HCV core protein. HCV core protein in sera was found to have exactly the same molecular weight as the p21 protein. These results suggest that p21 core protein is a component of native viral particles.
引用
收藏
页码:6048 / 6055
页数:8
相关论文
共 48 条
  • [11] HEPATITIS-C VIRUS PARTICLE DETECTED BY IMMUNOELECTRON MICROSCOPIC STUDY
    KAITO, M
    WATANABE, S
    TSUKIYAMAKOHARA, K
    YAMAGUCHI, K
    KOBAYASHI, Y
    KONISHI, M
    YOKOI, M
    ISHIDA, S
    SUZUKI, S
    KOHARA, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 1755 - 1760
  • [12] Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)
    Kashiwakuma, T
    Hasegawa, A
    Kajita, T
    Takata, A
    Mori, H
    Ohta, Y
    Tanaka, E
    Kiyosawa, K
    Tanaka, T
    Tanaka, S
    Hattori, N
    Kohara, M
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 190 (01) : 79 - 89
  • [13] SUSCEPTIBILITY OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTED CELL-LINE MT-2 TO HEPATITIS-C VIRUS-INFECTION
    KATO, N
    NAKAZAWA, T
    MIZUTANI, T
    SHIMOTOHNO, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (03) : 863 - 869
  • [14] MOLECULAR-CLONING OF THE HUMAN HEPATITIS-C VIRUS GENOME FROM JAPANESE PATIENTS WITH NON-A, NON-B HEPATITIS
    KATO, N
    HIJIKATA, M
    OOTSUYAMA, Y
    NAKAGAWA, M
    OHKOSHI, S
    SUGIMURA, T
    SHIMOTOHNO, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) : 9524 - 9528
  • [15] A MINIMAL AND OPTIMAL CYTOTOXIC T-CELL EPITOPE WITHIN HEPATITIS-C VIRUS NUCLEOPROTEIN
    KITA, H
    HIROISHI, K
    MORIYAMA, T
    OKAMOTO, H
    KANEKO, T
    OHNISHI, S
    YAZAKI, Y
    IMAWARI, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 3189 - 3193
  • [16] INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS
    KIYOSAWA, K
    SODEYAMA, T
    TANAKA, E
    GIBO, Y
    YOSHIZAWA, K
    NAKANO, Y
    FURUTA, S
    AKAHANE, Y
    NISHIOKA, K
    PURCELL, RH
    ALTER, HJ
    [J]. HEPATOLOGY, 1990, 12 (04) : 671 - 675
  • [17] EXPRESSION AND CHARACTERIZATION OF GLYCOPROTEIN GP35 OF HEPATITIS-C VIRUS USING RECOMBINANT VACCINIA VIRUS
    KOHARA, M
    TSUKIYAMAKOHARA, K
    MAKI, N
    ASANO, K
    YAMAGUCHI, K
    MIKI, K
    TANAKA, S
    HATTORI, N
    MATSUURA, Y
    SAITO, I
    MIYAMURA, T
    NOMOTO, A
    [J]. JOURNAL OF GENERAL VIROLOGY, 1992, 73 : 2313 - 2318
  • [18] AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS
    KUO, G
    CHOO, QL
    ALTER, HJ
    GITNICK, GL
    REDEKER, AG
    PURCELL, RH
    MIYAMURA, T
    DIENSTAG, JL
    ALTER, MJ
    STEVENS, CE
    TEGTMEIER, GE
    BONINO, F
    COLOMBO, M
    LEE, WS
    KUO, C
    BERGER, K
    SHUSTER, JR
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 362 - 364
  • [19] CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4
    LAEMMLI, UK
    [J]. NATURE, 1970, 227 (5259) : 680 - +
  • [20] ANALYSIS OF HEPATITIS-C VIRUS CAPSID, E1, AND E2/NS1 PROTEINS EXPRESSED IN INSECT CELLS
    LANFORD, RE
    NOTVALL, L
    CHAVEZ, D
    WHITE, R
    FRENZEL, G
    SIMONSEN, C
    KIM, J
    [J]. VIROLOGY, 1993, 197 (01) : 225 - 235